-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on XPLR Infr, Raises Price Target to $9

Benzinga·05/12/2025 14:21:35
Listen to the news
Barclays analyst Betty Jing maintains XPLR Infr (NYSE:XIFR) with a Underweight and raises the price target from $6 to $9.